Solid Biosciences LLC (SLDB) financials · $389.9M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Solid Biosciences LLC (SLDB) $389.9M cap.
| Line | FY2025 | FY2025 |
|---|---|---|
| Net Income | -$45.8M | -$39.5M |
| EPS (Diluted) | -$0.48 | -$0.42 |
| Line | Q3 2025 | Q2 2025 |
|---|---|---|
| Total Assets | $273.9M | $308.3M |
| Current Assets | $244.9M | $278.6M |
| Cash & Equivalents | $61.4M | $138.9M |
| PP&E | $4.36M | $4.32M |
| Total Liabilities | $56.0M | $50.0M |
| Current Liabilities | $36.3M | $29.8M |
| Shareholders' Equity | $217.9M | $258.3M |
| Retained Earnings | -$908.0M | -$862.2M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$100.0M | -$94.2M |
| Investing Cash Flow | -$16.1M | $9.69M |
| Financing Cash Flow | $122.4M | $3.12M |
FAQ
What is SLDB P/E and revenue?
Solid Biosciences LLC (SLDB) $389.9M cap.
What is SLDB revenue?
SLDB income-statement cache has no revenue figure yet.
Is SLDB profitable?
Solid Biosciences LLC last cached net income is -$45.8M (FY2025).
What are SLDB total assets?
Solid Biosciences LLC last cached total assets are $273.9M (Q3 2025).
What is SLDB free cash flow?
No cached cash-flow row for SLDB yet.
Not investment advice. Cached statements, not a live tape.